Part-chaotic retro shooter, part-stylish cartoon noir, Mouse P.I. for Hire goes beyond its stellar artistry to land an ...

Arc’s Value Village Thrift Store & Donation Center in Richfield, Minnesota falls firmly into the expedition category, ...

Compass Prep, based in Arizona, is a premier basketball-focused institution dedicated to developing top-level athletes. The school provides a rigorous basketball program with a strong emphasis on ...

Compass sued Zillow in June over its listing access standards, which threatened to ban listings that were not uploaded to its platform within 24 hours of being publicly marketed. Last month, a judge ...

Property brokerage Compass on Wednesday dropped its lawsuit against Zillow, ending a legal clash over how home listings can be marketed online. For the past few years, Compass — now the largest real ...

The industry’s largest brokerage had sued the home search site over its Listings Access Standards, which conflict with Compass’ marketing approach. Compass' signature 3-phased marketing strategy, in ...

Brokerage Compass dropped its lawsuit against Zillow after the listings giant said it would allow some pre-marketed homes on its platform, ending a multi-month fight between two real estate giants ...

Compass will share select off-MLS listings with Redfin under a new three-year agreement that could alter how some properties are marketed. LOS ANGELES — Compass will allow its property listings that ...

Compass’ fourth-quarter earnings call this week came with more than bottom-line metrics. The company announced a three-year partnership with Rocket and Redfin. The “strategic alliance,” as Compass ...

Copyright 2026 The Associated Press. All Rights Reserved. Copyright 2026 The Associated Press. All Rights Reserved. Add AP News on Google Add AP News as your ...

Phase 3 clinical trial data has been a success. COMP360 is the first traditional psychedelic to consistently deliver a highly statistically significant outcome. Results included maintaining a ...

Compass Pathways has reported another phase 3 win for its psilocybin therapy in treatment-resistant depression, sending the British biotech’s share price up 30% and teeing up talks about filing for ...